References
- Lideståhl, A, Permert, J, Linder, S, Bylund, H, Edsborg, N, Lind, P. Efficacy of systemic therapy in advanced pancreatic carcinoma. Acta Oncol 2005; in press.
- White RR, Hurwitz HI, Morse MA. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol 2001; 8(10)758–65
- White RR, Tyler DS. Neoadjuvant therapy for pancreatic cancer: The Duke experience. Surg Oncol Clin N Am 2004; 13(4)675–84, ix–x
- Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, et al. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg 2000; 135(1)81–7; discussion 88
- Snady H, Bruckner H, Cooperman A, Paradiso J, Kiefer L. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer 2000; 89(2)314–27
- Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998; 228(4)508–17
- Oya N. Chemoradiotherapy for pancreatic cancer: Current status and perspectives. Int J Clin Oncol 2004; 9(6)451–7
- Pasetto LM, Jirillo A, Stefani M, Monfardini S. Is there a role for chemoradiotherapy in the treatment of pancreatic carcinoma?. Anticancer Res 2003; 23(3C)2805–13
- Fung MC, Ishiguro H, Takayama S, Moriazane T, Adachi S, Sakata T. Survival benefit of chemotherapy treatment in advanced pancreatic cancer: A metaanalysis. Proc Am Soc Clin Oncol 2003; 22: 288 (abstract 1155)